BioSpace News Archive

Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the availability of the first Food and Drug Administration (FDA)-approved generic versions of TRUVADA ®i and ATRIPLA ®i tablets. “As the global leader in producing and supplying generics, Teva is excited to launch these medications which further our commitment to deli

IVERIC bio, Inc. (Nasdaq: ISEE) today reported that on October 1, 2020, the Company granted a newly hired employee a non-statutory option to purchase 14,000 shares of the Company’s common stock. This grant was made pursuant to the Company’s 2019 Inducement Stock Incentive Plan (as amended), was approved by the Company’s compensation committee pursuant to a delegation by the Company’s board of directors, and was made as a mater

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the Company will be hosting a virtual Investor Day on Tuesday, October 20 th from 11:00 a.m. ET to approximately 1:00 p.m. ET. Presenting during the event will be: John Higgins, Chief Executive Officer Matt Foehr, President and Chief Operation Officer Matt Korenberg, Chief Financial Officer

Case report demonstrated rapid resolution of hypoxemia and mobility and potential benefit of lenzilumab beyond the initial acute hyper-inflammatory window After 13 weeks of hospitalization, administration of lenzilumab resulted in rapid improvement in oxygenation and subsequent discharge BURLINGAME, Calif.--( BUSINESS WIRE )-- Humanigen, Inc. , (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused o

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a pioneer in developing treatments for phenylketonuria (PKU) and gene therapies, announced today that the U.S. Food and Drug Administrat

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the third quarter 2020 on Thursday, October 29, 2020, before the U.S. financial markets open. Novocure’s management will host a conference call and webcast to discuss its financial results for the three and nine months ended September 30, 2020, at 8 a.m. EDT on Thursday, October 29, 2020. Analysts and investors can participate in the conf

OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical anatomy in real-time during sur

As part of its continued efforts to connect healthcare specialists around the world with clinically relevant news and information, expert perspectives, and continuing education, HMP Global, a leading healthcare event and education company, today announced the launch of the Gastroenterology Learning Network.

COVID-19 continues to have deep and lingering financial impacts on the state’s hospitals.

First Order From Indian Distributor Is Substantially Larger Than Expected, Exceeding International Launch Expectations With Follow-Up Orders From Distributors in Singapore and Malaysia Anticipated